| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $35K | +104.5% |
| R&D Expense | $29K | -79.9% |
| SG&A Expense | $8.2M | +17.8% |
| Operating Income | -$8.4M | -15.5% |
| Interest Expense | $19K | -99.7% |
| Pre-tax Income | -$8.4M | -0.1% |
| Net Income | -$8.4M | -0.1% |
| EPS (Basic) | -$0.31 | +53.0% |
| EPS (Diluted) | -$0.31 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Accounts Receivable | $19K | +275.2% |
| Current Assets | $8.8M | +217.9% |
| Total Assets | $10.6M | +137.9% |
| Current Liabilities | $632K | -24.9% |
| Total Liabilities | $1.1M | -29.7% |
| Stockholders' Equity | $9.6M | +223.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +12.0% |
| Capital Expenditures | $215K | -62.7% |
| Investing Cash Flow | -$404K | +49.1% |
| Financing Cash Flow | $11.9M | +228.7% |
| Free Cash Flow | -$5.2M | +16.6% |
| +53.0% |